Clinical Trial Update: Evolocumab in Patients With Acute MI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on evolocumab in patients with acute coronary syndrome and acute myocardial infarction; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Repatha (Evolocumab)

Snippet

Sponsor: Johns Hopkins University | Conditions: Acute Coronary Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2025-10-23